Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 3/A Insider 3/A
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 8-K Event Bylaws or fiscal year change
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 424B4 Offering Prospectus
  12. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  13. EFFECT Other Notice of Effectiveness
  14. S-1MEF Other S-1MEF
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 17 of 19 · 365 filings